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Abstract 12 
The thiazolyl blue tetrazolium bromide (MTT) assay was used to study the potential interactions 13 
between several active compounds from plant essential oils (carvacrol, eugenol, cinnamaldehyde, 14 
thymol and eucalyptol) when used as antibacterial agents against Escherichia coli and Listeria 15 
innocua. The minimum inhibitory concentration (MIC) of each active compound and the fractional 16 
inhibitory concentration (FIC) index for the binary combinations of essential oil compounds were 17 
determined. According to FIC index values, some of the compound binary combinations showed 18 
an additive effect, but others, such as carvacrol-eugenol and carvacrol-cinnamaldehyde exhibited 19 
a synergistic effect against L. innocua and E. coli, which was affected by the compound ratios. 20 
Some eugenol-cinnamaldehyde ratios exhibit an antagonistic effect against E. coli, but a 21 
synergistic effect against L. innocua. The most remarkable synergistic effect was observed for 22 
carvacrol-cinnamaldehyde blends for both E. coli and L. innocua, but using different compound 23 
ratios (1:0.1 and 0.5:4 respectively for each bacteria).  24 
 25 
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1. Introduction 27 
Foodborne pathogens and spoilage bacteria are the major concerns of food companies, since they 28 
produce a large amount of food waste with the consequent economic losses, as well as causing 29 
important foodborne illnesses, which is one of the major global health preoccupations (Ghabraie, 30 
Vu, Tata, Salmieri, & Lacroix, 2016). Synthetic preservatives have been widely used for decades to 31 
maintain quality, extend the shelf life and ensure the safety of foodstuffs (Jaiswal & Jaiswal, 32 
2015). However, their repeated applications have led to chemical residue accumulation in the 33 
food chain and the development of microbial resistance and side effects for human health 34 
(Akinyemi, Oluwa, & Omomigbehin, 2006). For these reasons, consumer preferences are changing 35 
toward safer, natural food preservatives. In this context, essential oils (EOs) and several of their 36 
constituents represent a natural, safe alternative to chemical food preservatives, due to their 37 
capacity to inhibit the growth of a wide variety of pathogenic and food-spoiling microorganisms 38 
including bacteria, fungi and yeasts (Conner &Beuchat, 1984; Ghabraie et al., 2016; Wilson, Solar, 39 
El Ghaouth, & Wisniewski, 1997). Thus, carvacrol, which is the main compound of oregano EO, has 40 
been effective at inhibiting the growth and survival of several foodborne and spoilage bacteria, 41 
such as Listeria monocytogenes, Aeromonas hydrophila, Pseudomonas fluorescens (de Sousa et 42 
al., 2012) and different strains of Escherichia coli (Stratakos et al., 2018), as well as some 43 
important foodborne fungal pathogens (Abbaszadeh, Sharifzadeh, Shokri, Khosravi, & 44 
Abbaszadeh, 2014). Carvacrol is also present in thyme EO, where thymol is the most abundant 45 
active compound. Several in vivo studies demonstrated that thymol exhibits antimicrobial activity 46 
against a broad spectrum of Gram negative or Gram-positive bacteria (Moon & Rhee, 2016) and 47 
fungi (Abbaszadeh et al., 2014). Eugenol is the main compound of cinnamon leaf EO (70-95%), 48 
which also contains cinnamaldehyde in a proportion of 1 to 5% (Vangalapati, Satya Prakash & 49 
Avanigadda, 2012). Both active compounds have exhibited significant antimicrobial effects in in 50 
vitro tests against different foodborne pathogens, such as Staphylococcus sp., Micrococcus sp., 51 
Bacillus sp. Enterobacter sp. (Moleyar, & Narasimham, 1992), Escherichia coli (Pei, Zhou, Ji, & Xu, 52 
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2009) and Helicobacter pylori (Ali et al., 2005). Eucalyptol, which occurs in different active 53 
aromatic plants such as oregano, rosemary, thyme and ginger, also has proven broad-spectrum 54 
antimicrobial activity that includes the inhibition of both Gram-positive (Listeria monocytogenes, 55 
Staphylococcus aureus, Bacillus cereus and Enterococcus faecalis) and Gram-negative bacteria (E. 56 
coli, Aeromonas hydrophila, Pseudomonas aeruginosa and fluorescens, Klebsiella pneumoniae and 57 
Moraxella catarrhalis) (de Oliveira et al., 2015; Van Vuuren & Viljoen, 2007).  58 
However, the concentrations of the EOs or their constituents required to inhibit bacterial growth 59 
in foods can modify the taste or exceed the acceptable flavour threshold of food products 60 
(Gutierrez, Barry-Ryan & Bourke, 2008). In this sense, the potential synergistic activity of these EO 61 
compounds has appeared as an alternative means of reducing the active doses needed to achieve 62 
antimicrobial effects in food, since several authors have demonstrated some synergistic 63 
interactions against several foodborne pathogens in in vitro studies combining carvacrol, thymol, 64 
eugenol, cinnamaldehyde and eucalyptol (de Sousa et al., 2012; Guarda, Rubilar, Miltz, & Galotto, 65 
2011; Hill, Gomes, & Taylor, 2013; Pei et al.,2009; Van Vuuren & Viljoen, 2007).  66 
Nevertheless, it is very difficult to compare the published results for the same EO compounds, 67 
since there are several factors that influence their antimicrobial effects. The most important 68 
variable is the antimicrobial test method, including incubation temperature, inoculum size and 69 
test microorganisms (Lambert, & Pearson, 2000; Nostro, Germano, D’Angelo, Marino, & 70 
Cannatelli, 2000). Therefore, it is necessary to standardize the antimicrobial activity assessment in 71 
order to obtain comparable and reproducible results.  72 
Diffusion methods (agar disk diffusion and agar well diffusion) have been widely used to screen 73 
the antimicrobial activity of EOs and their main compounds (Huang, Chen, Hung, & Kao, 2012; 74 
Stratakos et al., 2018); however, these tests do not permit the quantification of their bioactivity in 75 
terms of minimum inhibitory concentration (MIC), since they are qualitative tests (Ncube, 76 
Afolayan, & Okoh, 2008). Likewise, methods in vapour-phase, such as the disk volatilization assay, 77 
have been used in many studies for the antimicrobial evaluation of EOs in vapour-phase, but they 78 
only allow us to identify the most effective compound from several active ingredients (Bueno, 79 
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2015; Houdkova, Rondevaldova, Doskocil, & Kokoska, 2017). Moreover, these tests are not able to 80 
perform a large-scale screening with many different active compounds at different 81 
concentrations. Some other methods used to determine the EO compounds’ antimicrobial 82 
activity, such as the agar-plate method for total microbial count, are resource-intensive and time-83 
consuming (Clark, 1965), and more sophisticated studies, such as flow cytometry or tests based 84 
on absorbance measurement, require special equipment which is not commonly available 85 
(Gunasekera, Attfield, & Veal, 2000; Krepker et al., 2017).  86 
The thiazolyl blue tetrazolium bromide (MTT) colorimetric assay is one of the most useful 87 
methods for the evaluation of in vitro cell viability using microtiter plate design or the broth 88 
microdilution method (Houdkova et al, 2017), which has been used to study EO antimicrobial 89 
susceptibility (Houdkova et al, 2017; Ye, Shen, Xu, Lin, Yuan, & Jones, 2013), as well as drug 90 
interactions against bacteria (Rondevaldova, Novy, Urban, & Kokoska, 2017) and fungi (Te 91 
Dorsthorst, Verweij, Meis, Punt, & Mouton, 2002). This checkerboard experiment avoids the need 92 
for culturing procedures and could allow for distinguish between bacteriostatic and bactericidal 93 
effects and, therefore, obtain an easy and rapid quantitative determination of the MIC of large 94 
numbers of samples (Ncube et al., 2008), unlike the antimicrobial susceptibility methods based on 95 
colony counting by decimal dilution and agar plating, which are not able to check many different 96 
active compounds and concentrations within a short time (Pei et al., 2009). Moreover, the MTT 97 
assay is an inexpensive and reproducible test, which can be used for a wide variety of 98 
microorganisms, since the use of the MTT reagent as a colorimetric indicator avoids the need for a 99 
spectrophotometric plate reader. Nonetheless, EO compounds can alter the results of microplate 100 
toxicity assays, due to their volatile nature (Novy et al., 2014). Thus, it is advisable to use an 101 
effective vapour barrier, such as a sealer mat made of non-reactive rubber, to avoid vapour 102 
transmission between adjacent wells (Houdkova et al., 2017; Rondevaldova et al., 2017). 103 
To the best of our knowledge, the potential use of the MTT assay as a tool with which to 104 
determine the possible interactions between different active compounds of essential oils at 105 
controlling microbial growth has been little explored. The aim of this study was to analyse the 106 
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potential synergistic activity of the most effective antimicrobial compounds from EOs (carvacrol, 107 
eugenol, cinnamaldehyde, thymol and eucalyptol) against E. coli and L. innocua using MTT assay. 108 
E. coli was chosen as model for pathogenic Gram-negative bacteria (Sondi & Salopek-Sondi, 2004), 109 
whereas L. innocua was selected as representative strain of L. monocytogenes (model Gram-110 
positive bacteria), because of its non-pathogenicity to humans (Coma, Sebti, Pardon, Deschamps, 111 
& Pichavant, 2001) and similar sensitivity to EO compounds (Teixeira et al., 2013.). 112 
 113 
2. Materials and methods 114 
2.1. Reagents and bacterial strains 115 
Carvacrol, eugenol, cinnamaldehyde, thymol, eucalyptol and MTT reagent were supplied by 116 
Sigma-Aldrich (Steinheim, Germany). Dimethyl sulfoxide (DMSO) was purchased from Panreac 117 
(Barcelona, Spain), whereas sterile Phosfate Buffered Saline (PBS), Tryptone Soy Broth (TSB) and 118 
Tryptone Soy Agar (TSA) were supplied by Scharlab (Barcelona, España).  119 
Listeria innocua (CECT 910) and Escherichia coli (CETC 101) lyophilized strains were supplied by 120 
the Spanish Type Culture Collection (CECT, Universitat de València, Spain), and stored at −40 °C 121 
with 30% glycerol. Active cultures were regenerated by inoculating the microbial stock 122 
suspensions into TSB followed by their incubation at 37 °C for 24 h. The inoculums were properly 123 
diluted to obtain bacterial suspensions of 105 CFU/mL. 124 
 125 
2.2. MIC assessment and combined antimicrobial effects  126 
A MTT colorimetric assay was carried out by using a 96-well disposable sterile microtiter plate 127 
design in order to determine the MIC of the different EO compounds (Figure 1). Stock solutions of 128 
each EO compound (10 mg/mL) were obtained using DMSO as emulsifier. Diluted EO solutions 129 
were prepared from stock solutions using TSB broth medium as solvent and aliquots of 100 µL of 130 
each dilution were placed in their corresponding wells, thus obtaining EO concentrations from 131 
0.05 to 2.5 mg/mL. To this end, the concentration of each EO compound was increased 0.05 132 
mg/mL between two consecutive wells. Then, plates were inoculated with 100 µL of the 105 133 
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CFU/mL bacterial suspension and covered with an autoclavable sterile sealer mat as an effective 134 
vapour barrier to prevent the volatile compounds from contaminating the adjoining wells. Sterility 135 
and bacterial growth control were also prepared with non-inoculated and inoculated culture 136 
media, whereas the outer wells were left empty to prevent edge effect. All experiments were 137 
carried out in sterile conditions within a laminar flow cabinet and all culture media were properly 138 
autoclaved. 139 
After 24 h incubation at 37 oC, 10 µl of MTT reconstituted in PBS at 5 mg/mL were added to each 140 
well and incubated for 4h at 37 oC. MTT is a yellow tetrazolium salt, which is reduced to a purple 141 
formazan by dehydrogenases of a live cell. Thus, the formazan amount produced is directly 142 
proportional to the number of live cells and the MIC of the EO compounds can be assessed by the 143 
naked eye (Ye et al., 2013). In this way, the MIC values were determined as the lowest 144 
concentration of active compound at which no purple colour was observed. All the experiments 145 
were carried out in duplicate. 146 
The potential synergistic effects of binary combinations of the different EO compounds were also 147 
tested by the chequerboard method. EO compound stock solutions were prepared in DMSO and 148 
properly diluted in TSB to obtain binary combinations with final concentrations of each active 149 
compound that ranged from the MIC values to 1:100 dilution below the corresponding MIC. The 150 
microtiter plate design allowed the concentrations of each antimicrobial to be varied along the 151 
different axes, thus ensuring that each well of the plate represents a different combination 152 
(Figure 2a). The antimicrobial effects of each binary combination were evaluated by calculating 153 
the fractional inhibitory concentration (FIC) index, following Eq. (1). As shown in the theoretical 154 
isobologram (Figure 2b), it was considered to be a synergistic action when the FIC index was lower 155 
than 1, additivity when the FIC was 1, and an antagonistic effect when the FIC was higher than 1 156 
(Bell, 2005; Krepker et al., 2017; Pei et al., 2009). All the concentrations were tested in duplicate. 157 
 158 
FICindex = FICA + FICB      (1) 159 
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where  160 
FICA = MICA in presence of B /MICA alone 161 
FICB = MICB in presence of A /MICB alone.  162 
 163 
3. Results and discussion 164 
3.1. Minimum inhibitory concentration 165 
All the active components evaluated exhibited antibacterial activity against E. coli and L. innocua, 166 
with values of MIC ranging from 0.5 to 1.75 mg/mL (Table 1). Cinnamaldehyde was the most 167 
effective at inhibiting the growth (lowest MIC) of both bacteria, and the reported MIC was similar 168 
to that found by other authors (Hill et al., 2013; Ye et al., 2013). As reported de Sousa et al. (2012) 169 
and Van Vuuren & Viljoen (2007) for L. monocytogenes and E. coli, respectively, eucalyptol was 170 
the least effective at inhibiting bacterial growth, E. coli being more resistant. Likewise, in 171 
accordance with the MIC reported by Pei et al. (2009) and Hill et al. (2013) for E. coli and L. 172 
innocua, respectively, eugenol showed lower values as compared to cinnamaldehyde, carvacrol 173 
and thymol, being more effective against L. innocua. 174 
Carvacrol and thymol, with very similar molecular structures (Table 1), showed similar MIC values 175 
for both bacteria, E. coli being more affected than L. innocua. This coincides with that obtained in 176 
previous studies, although the MIC values were slightly lower (Guarda et al., 2011; Du et al., 177 
2015). The differences in terms of the MIC values for the same active component and bacterial 178 
strain can be explained by the different methodology applied, the culture media used, inoculum 179 
size, pH, incubation time and temperature (Pei et al., 2009). 180 
 181 
3.2. Interactions between components in binary active compound mixtures 182 
The potential synergistic antibacterial effect of all binary combinations of the compounds were 183 
determined quickly and easily by calculating the fractional inhibitory concentration (FIC) index, 184 
thus obtaining the isobolograms for the different active binary mixtures against L. innocua (Figure 185 
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3) and E. coli (Figure 4). It was considered to be a synergistic action when the FIC index was lower 186 
than 1, additivity when the FIC index was 1, and an antagonistic effect when the FIC index was 187 
higher than 1 (Bell, 2005; Krepker et al., 2017; Pei et al., 2009). The binary combinations that 188 
exhibit a synergistic effect with the lowest FIC index values are given in Table 2 for both E. coli and 189 
L. innocua.  190 
Santiesteban-Lopez et al. (2007) reported some generally accepted mechanisms for synergistic 191 
action of the antimicrobial combinations: the sequential inhibition of a common biochemical 192 
pathway, inhibition of protective enzymes, combinations of cell wall active agents, or the action of 193 
cell wall active agents to enhance the uptake of other antimicrobials. Likewise, there are 194 
mechanisms that produce antagonism for the antimicrobial combinations. Although these are less 195 
known, generally they include the combinations of bactericidal and bacteriostatic agents, the use 196 
of compounds that act on the same target of the microorganism, or chemical interactions among 197 
the active compounds (Goñi et al., 2009). 198 
Carvacrol/cinnamaldehyde combinations exhibited a synergistic effect against E. coli for almost all 199 
combination ratios (Figure 4), but the synergistic effect against L. innocua (Figure 3) was only 200 
observed when cinnamaldehyde was the major component in the mixture. Ye el al. (2013) also 201 
reported strong synergistic activity for carvacrol/cinnamaldehyde combinations against 7 kinds of 202 
bacteria, including E. coli. In contrast, almost all the eugenol/cinnamaldehyde combinations 203 
exhibited an antagonistic effect against E. coli and L. innocua. On the contrary, Pei et al. (2009) 204 
found a synergistic action between eugenol and cinnamaldehyde against E. coli and only an 205 
additive effect between carvacrol and cinnamaldehyde for the same bacteria. Wendakoon and 206 
Sakaguchi (1993) hypothesized that the hydroxyl group on eugenol might combine with proteins, 207 
preventing enzyme action while the carbonyl group on cinnamaldehyde might adhere to proteins 208 
to prevent the action of amino acid decarboxylases. 209 
Every ratio of eugenol/carvacrol combinations showed an antagonistic effect against L. innocua, 210 
whereas either synergistic or additive effects were observed against E. coli, depending on the 211 
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ratio of both components. Similarly, no synergistic effects were observed for different ratios of 212 
eugenol/carvacrol combinations against L. innocua by García‐García, López‐Malo, & Palou (2011). 213 
Carvacrol and thymol were hydrophobic and prone to disturb the outer membrane of Gram-214 
negative bacteria, releasing lipopolysaccharides, and increasing the permeability of the 215 
cytoplasmic membrane to ATP (Helander and others 1998; Lambert and others 2001). Based 216 
these previous studies, the synergistic effects of eugenol/carvacrol and eugenol/thymol might be 217 
associated with the fact that carvacrol and thymol can disintegrate the outer membrane of E. coli, 218 
making it easier for eugenol to enter the cytoplasm and combine with proteins. 219 
As concerns carvacrol/thymol combinations, an antagonistic effect was observed for E. coli at 220 
every ratio while a mild synergistic action was detected for L. innocua at the highest carvacrol 221 
ratio (Table 2). In contrast, Pei et al. (2003) observed a synergistic activity of these compounds 222 
against E. coli. However, other authors (Gallucci et al., 2009; Rivas et al., 2010) did not find that 223 
positive interactions between these compounds improved their antibacterial action. The 224 
occurrence of an additive or indifferent interaction between carvacrol and thymol could be 225 
related to the similarity in their molecular structures (they are isomers), suggesting a similar 226 
mechanism of action.  227 
Despite the different molecular structure of carvacrol and eucalyptol, which could promote a 228 
different mechanism of action, antimicrobial activity was not promoted in the 229 
carvacrol/eucalyptol mixtures, in contrast with that reported by de Sousa et al. (2012) and de 230 
Oliveira et al. (2015). In fact, binary combinations with eucalyptol were the least effective in most 231 
cases, in line with its higher MIC value for both bacteria. So, its antibacterial activity was the 232 
lowest, both alone or combined with other, more active compounds. Only when combined with a 233 




Compound combinations, given in Table 2, allow for greater antibacterial action than that 236 
achieved with the respective, pure compounds, using a lower total amount of actives. It is 237 
remarkable that wider synergistic spectrum was obtained for L. innocua than for E. coli, which 238 
could be related with the different bacteria cell envelope of Gram-positive and Gram-negative 239 
bacteria. Gram-positive bacteria surrounded by layers of peptidoglycan, many times thicker than 240 
is found in E. coli, could be more sensitive to the combined action of different compounds that are 241 
able to interact with the bacteria cell envelope to a different extent. The compound combination 242 
that was best at controlling the growth of E. coli was carvacrol/cinnamaldehyde (1:0.1 ratio), 243 
whose MIC value was 0.55 mg/mL. This combination was also the most effective against L. 244 
innocua (MIC value 0.45 mg/mL), but when using a caravacrol/cinnamaldehyde ratio of 0.5:4.  245 
 246 
4. Conclusions 247 
The MTT method was effective at evaluating the potential synergistic antibacterial effect simply 248 
and quickly through the FIC index assessment of blends of active components from essential oils, 249 
which can be easily standardized. This method provided reliable MIC values of the active 250 
compounds, as well as the FIC index value of their binary combinations over a wide concentration 251 
range below the respective MICs. The most remarkable synergistic effect was observed for 252 
carvacrol/cinnamaldehyde blends for both E. coli and L. innocua, but using different compound 253 
ratios (1:0.1 and 0.5:4 respectively for each bacteria). In general, the obtained results concerning 254 
the synergistic effects of the EO components agree with those reported by other authors, 255 
although some discrepancies were obtained that are attributable to the antimicrobial 256 
susceptibility method used (temperature, culture media, pH, bacterial strain, …). Likewise, the 257 
MTT method allows for a wide range of concentrations to be tested, which better permits the 258 
estimation of the optimal ratio of active compounds with which to obtain the maximum synergy.  259 
The synergistic effect was more notable in Listeria innocua than in Escherichia coli. The obtained 260 
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results allowed the dose of active compounds used for food application purposes to be optimized, 261 
thus minimizing their sensory impact.  262 
 263 
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Table 1. Minimum inhibitory concentration (MIC) of the different active compounds tested 391 
against E. coli and L. innocua 392 
Active compound                           Molecular structure 
MIC (mg/mL) 




















Table 2. Binary combinations with the highest synergistic effect (lowest FIC index) against L. 395 
innocua and E. coli. 396 
 
E. coli L. innocua 
Synergistic combination (A/B) A (mg/mL) B (mg/mL) A (mg/mL) B (mg/mL) 
Carvacrol/Cinnamaldehyde 0.50 0.05 0.05 0.40 
Carvacrol/Thymol nf nf 0.60 0.10 
Eugenol/Carvacrol 0.40 0.45 0.90 0.10 
Eugenol/Cinnamaldehyde 0.80 0.10 0.20 0.40 
Eugenol/Thymol nf nf 0.90 0.05 
Eucalyptol/Thymol nf nf 1.00 0.05 
Eucalyptol/Cinnamaldehyde nf nf 1.00 0.10 
Thymol/Cinnamaldehyde nf nf 0.45 0.10 








Figure 1. Experimental design for the determination of the minimum inhibitory concentration 402 
(MIC) of three different active compounds (A, B and C), with their respective duplicates. Sterility 403 
and growth control were prepared with non-inoculated and inoculated culture media, whereas 404 


























Figure 2. (a) Experimental design for the determination of the fractional inhibitory concentration 429 
(FIC) for each active compound in a binary mixture. Sterility and growth control were prepared 430 
with non-inoculated and inoculated culture media, whereas the outer wells were left empty to 431 
avoid edge effect. (b) Theoretical isobolograms displaying the three types of possible effects 432 






























Figure 3. Isobolograms showing the fractional inhibitory concentration (FIC) for the binary 457 
combinations of the active compounds (carvacrol (CA), eugenol (EU), cinnamaldehyde (CIN), 458 

































Figure 4. Isobolograms showing the fractional inhibitory concentration (FIC) for the binary 490 
combinations of the active compounds (carvacrol (CA), eugenol (EU), cinnamaldehyde (CIN), 491 




Figure captions 494 
Figure 1. Experimental design for the determination of the minimum inhibitory concentration 495 
(MIC) of three different active compounds (A, B and C). Sterility and growth control were 496 
prepared with non-inoculated and inoculated culture media, whereas the outer wells were left 497 
empty to avoid edge effect. 498 
Figure 2. (a) Experimental design for the determination of the fractional inhibitory concentration 499 
(FIC) for each active compound in a binary mixture. Sterility and growth control were prepared 500 
with non-inoculated and inoculated culture media, whereas the outer wells were left empty to 501 
avoid edge effect. (b) Theoretical isobolograms displaying the three types of possible effects 502 
(additivity, antagonism and synergy), according to the FIC index values. 503 
Figure 3. Isobolograms showing the fractional inhibitory concentration (FIC) for the binary 504 
combinations of the active compounds (carvacrol (CA), eugenol (EU), cinnamaldehyde (CIN), 505 
thymol (THY), eucalyptol (EUCA)) against L. innocua.  506 
Figure 4. Isobolograms showing the fractional inhibitory concentration (FIC) for the binary 507 
combinations of the active compounds (carvacrol (CA), eugenol (EU), cinnamaldehyde (CIN), 508 
thymol (THY), eucalyptol (EUCA)) against E. coli. 509 
